Demo Marketing Trials 
BioPharma Drive: Drug Pricing
JULY 28, 2025
Fragmented approaches – whether through retail or oversized specialty hub models, or limited alternative solutions that lack true integration – simply cannot deliver the efficiency, control, and customization that market-defining brands need. Book a demo to discover how PHIL can help your specialty-lite brands secure commercial success.
H1 Blog
JUNE 7, 2023
Clinical trial success is a key factor for pharma companies when designing and recruiting patients into trials. This data can also provide guidance in terms of diversifying clinical trials to include different types of population demographics such as age, gender, race, ethnicity, or geographic location.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
H1 Blog
OCTOBER 16, 2023
AI can help in speeding up various phases like target identification, molecule optimization, and pre-clinical testing, thereby reducing the cost and time to bring a drug to market. Faster Time-to-Market: AI-driven predictive maintenance can reduce machine downtime, ensuring smoother manufacturing processes and quicker product delivery.
H1 Blog
DECEMBER 11, 2024
In this edition, our CEO and co-founder, Ariel Katz, along with Regional VP of Trial Landscape, Ryan Brown, share their top predictions for 2025. Drug Policy There will be significant changes in clinical trials & drug development due to the Inflation Reduction Act.
H1 Blog
NOVEMBER 29, 2023
Breaking the Barriers: How Inaccurate Trial Records Are Delaying Drug Development and Limiting Diverse Patient Populations In an October 2023 report , BMC Medicine completed a follow-up on a 10-year effort to understand, report on and track data sharing challenges with big pharma, specifically for clinical trials.
H1 Blog
JULY 30, 2024
Increasing diversity in clinical trials not only makes the findings more relevant to various patient groups, but also enhances knowledge about the disease or medical product being studied. This allows the trial to achieve more precise results at the indication level through leveraging comprehensive information from across the globe. “I
H1 Blog
JULY 5, 2023
The success of drug development and approval relies heavily on the ability to identify diverse patient populations for clinical trials. From trial site feasibility to successful trial recruitment, diversity within a trial population helps ensure the safety and efficacy of drugs that reach the market.
Expert insights. Personalized for you.
Let's personalize your content